Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices
The Working Group on Access to Medicines and Treatments urged the Department of Pharmaceuticals to replace Dr. Naresh Trehan, chairman of Medanta, on a panel addressing pharma marketing practices due to potential conflicts of interest. The group argues that his involvement could undermine the panel's integrity. A decision from the government is anticipated soon.